PHARMACIE DES COLLONGES : revenue, balance sheet and financial ratios

PHARMACIE DES COLLONGES is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-GENIS-LAVAL (69230), this company of category PME shows in 2020 a revenue of 2.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DES COLLONGES (SIREN 799979158)
Indicator 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C 2 272 329 € 2 173 358 € 2 136 307 € 1 933 509 €
Net income 98 163 € 186 015 € 100 479 € 83 191 € 139 220 € 155 652 € 123 752 €
EBITDA N/C N/C N/C 134 031 € 200 810 € 234 595 € 211 400 €
Net margin N/C N/C N/C 3.7% 6.4% 7.3% 6.4%

Revenue and income statement

In 2023, PHARMACIE DES COLLONGES generates positive net income of 98 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 124 k€ -> 98 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

98 163 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 62%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 53%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

61.614%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

52.746%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

32.0%

Solvency indicators evolution
PHARMACIE DES COLLONGES

Sector positioning

Debt ratio
61.61 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good -11 pts over 3 years

In 2023, the debt ratio of PHARMACIE DES COLLONGES (61.61) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
52.75% 2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good +14 pts over 3 years

In 2023, the financial autonomy of PHARMACIE DES COLLONGES (52.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 171.20. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

171.198

Liquidity indicators evolution
PHARMACIE DES COLLONGES

Sector positioning

Liquidity ratio
171.2 2023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Average

In 2023, the liquidity ratio of PHARMACIE DES COLLONGES (171.20) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DES COLLONGES

Positioning of PHARMACIE DES COLLONGES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of PHARMACIE DES COLLONGES is estimated at 1 158 271 € (range 704 400€ - 1 628 270€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
704k€ 1158k€ 1628k€
1 158 271 € Range: 704 400€ - 1 628 270€
NAF 5 année 2023

Valuation method used

Net Income Multiple
98 163 € × 11.8x = 1 158 272 €
Range: 704 401€ - 1 628 270€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DES COLLONGES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DES COLLONGES

What is the revenue of PHARMACIE DES COLLONGES ?

The revenue of PHARMACIE DES COLLONGES in 2020 is 2.3 M€.

Is PHARMACIE DES COLLONGES profitable?

Yes, PHARMACIE DES COLLONGES generated a net profit of 98 k€ in 2023.

Where is the headquarters of PHARMACIE DES COLLONGES ?

The headquarters of PHARMACIE DES COLLONGES is located in SAINT-GENIS-LAVAL (69230), in the department Rhone.

Where to find the tax return of PHARMACIE DES COLLONGES ?

The tax return of PHARMACIE DES COLLONGES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DES COLLONGES operate?

PHARMACIE DES COLLONGES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.